secwatch / observer
8-K filed January 30, 2026, 6:59 PM ET ticker AWHL CIK 0000926617
debt confidence high sentiment neutral materiality 0.50

Aspira Women's Health enters $1.05M subordinated loan with Agile Lending, maturing Aug 2026

Aspira Women's Health Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Aspira Women's Health Inc. incurred term loan of $1,050,000 with Agile Lending, LLC at interest charges of $441,000 (assuming all payments are made on time) maturing August 26, 2026.

Instrument
term loan
Principal
$1,050,000
Counterparty
Agile Lending, LLC
Rate
interest charges of $441,000 (assuming all payments are made on time)
Maturity
August 26, 2026
Event
incurrence
Exact text from the filing
On January 30, 2026, Aspira Women’s Health Inc. (the “ Company ”) entered into a Subordinated Business Loan and Security Agreement (the “ Subordinated Loan Agreement ”) with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent, pursuant to which the Lenders (as such term is defined in the Subordinary Loan Agreement) agreed to make a secured term loan to the Company and certain subsidiary co-borrowers. The Subordinated Loan Agreement is dated as of January 30, 2026. ​ The term loan is evidenced by a Subordinated Secured Promissory Note (the “ Note ”) in the form attached to the Subordinated Loan Agreement. The Note was issued in the principal amount of $1,050,000, will include interest charges of $441,000 (assuming all payments are made on time), and is scheduled to mature on August 26, 2026.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Aspira Women's Health Inc. entered into Subordinated Loan Agreement with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent valued at $1,050,000 (effective 2026-01-30).

Action
entry
Agreement
credit facility
Counterparty
Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent
Value
$1,050,000
Effective
2026-01-30
Exact text from the filing
On January 30, 2026, Aspira Women’s Health Inc. (the “ Company ”) entered into a Subordinated Business Loan and Security Agreement (the “ Subordinated Loan Agreement ”) with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent
View on SEC.gov

306 debt financings filed in the last 30 days. Browse all debt financings →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR
accession 0000926617-26-000007
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.